← FDA DRUG APPROVALS
FDA ANDA · ANDA078933
ALLERGY RELIEF
cetirizine hydrochloride
Sponsor: MARKSANS PHARMA
APPLICATION
ANDA078933
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-15
LATEST ACTION
2023-04-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
CETIRIZINE HYDROCHLORIDE HIVESOver-the-counter
CETIRIZINE HYDROCHLORIDE 5MG · TABLET · ORAL
CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 5MG · TABLET · ORAL
CETIRIZINE HYDROCHLORIDE HIVESOver-the-counter
CETIRIZINE HYDROCHLORIDE 10MG · TABLET · ORAL
CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 10MG · TABLET · ORAL
Approval history
2023-04-13Manufacturing (CMC) · Supplement 5 · unknownAP
2010-06-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.